$901 Million is the total value of Broadfin Capital, LLC's 64 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 41.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON PHARMA PLC | $96,430,000 | -3.4% | 5,959,819 | +8.3% | 10.71% | +19.7% |
| PGNX | PROGENICS PHARMACEUTICALS IN | $77,338,000 | +36.5% | 8,951,169 | 0.0% | 8.59% | +69.1% | |
| RTRX | Sell | RETROPHIN INC | $61,887,000 | -20.3% | 3,269,271 | -5.8% | 6.87% | -1.3% |
| HRTX | Buy | HERON THERAPEUTICS INC | $51,085,000 | +4.0% | 3,899,587 | +36.8% | 5.67% | +28.9% |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $45,658,000 | -16.2% | 4,394,464 | 0.0% | 5.07% | +3.8% | |
| ATRS | Sell | ANTARES PHARMA INC | $30,223,000 | +20.9% | 12,971,093 | -12.9% | 3.36% | +49.7% |
| PETX | Buy | ARATANA THERAPEUTICS INC | $26,533,000 | -8.1% | 3,695,442 | +19.7% | 2.95% | +13.8% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $26,476,000 | -23.1% | 1,510,316 | +4.4% | 2.94% | -4.7% |
| ENDP | Buy | ENDO INTL PLC | $25,694,000 | -12.3% | 1,560,038 | +7.3% | 2.85% | +8.6% |
| REPH | Buy | RECRO PHARMA INC | $24,987,000 | +15.4% | 3,100,086 | +26.5% | 2.77% | +42.9% |
| ANGO | Sell | ANGIODYNAMICS INC | $24,818,000 | -51.1% | 1,471,152 | -49.1% | 2.76% | -39.4% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $23,472,000 | +70.0% | 647,500 | +115.8% | 2.61% | +110.7% |
| ARLZ | Buy | ARALEZ PHARMACEUTICALS INC | $21,131,000 | -1.1% | 4,791,590 | +8.7% | 2.35% | +22.4% |
| LBIO | LION BIOTECHNOLOGIES INC | $18,336,000 | -15.6% | 2,638,259 | 0.0% | 2.04% | +4.6% | |
| GNMX | New | AEVI GENOMIC MEDICINE INC | $17,458,000 | – | 3,370,306 | +100.0% | 1.94% | – |
| NVLNF | New | NOVELION THERAPEUTICS INC | $16,407,000 | – | 1,948,554 | +100.0% | 1.82% | – |
| MDCO | Buy | MEDICINES CO | $14,811,000 | +53.5% | 436,400 | +70.7% | 1.64% | +90.3% |
| VCYT | New | VERACYTE INC | $13,841,000 | – | 1,788,266 | +100.0% | 1.54% | – |
| DSCI | DERMA SCIENCES INC | $13,323,000 | +11.3% | 2,562,104 | 0.0% | 1.48% | +38.0% | |
| HZNP | Sell | HORIZON PHARMA PLCcall | $12,944,000 | -32.0% | 800,000 | -23.8% | 1.44% | -15.8% |
| TLGT | Sell | TELIGENT INC NEW | $12,769,000 | -23.7% | 1,931,711 | -12.3% | 1.42% | -5.5% |
| PRTK | PARATEK PHARMACEUTICALS INC | $12,106,000 | +18.4% | 786,134 | 0.0% | 1.34% | +46.6% | |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $12,110,000 | -4.1% | 644,153 | +6.5% | 1.34% | +18.7% |
| RXDX | IGNYTA INC | $11,960,000 | -15.7% | 2,256,546 | 0.0% | 1.33% | +4.4% | |
| DRRX | Buy | DURECT CORP | $11,398,000 | +28.2% | 8,506,229 | +33.0% | 1.26% | +58.7% |
| ADXS | Sell | ADVAXIS INC | $10,878,000 | -35.0% | 1,519,259 | -2.9% | 1.21% | -19.4% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $9,448,000 | -32.6% | 5,398,794 | +4.0% | 1.05% | -16.5% |
| ZGNX | Sell | ZOGENIX INC | $9,312,000 | -7.7% | 766,412 | -13.1% | 1.03% | +14.4% |
| BCR | New | BARD C R INC | $9,031,000 | – | 40,200 | +100.0% | 1.00% | – |
| New | EGALET CORPnote 5.500% 4/0 | $8,923,000 | – | 10,000,000 | +100.0% | 0.99% | – | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $8,728,000 | -18.5% | 2,833,649 | -15.6% | 0.97% | +0.9% |
| SPNE | SEASPINE HLDGS CORP | $8,690,000 | -21.9% | 1,100,007 | 0.0% | 0.96% | -3.2% | |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $8,617,000 | – | 83,500 | +100.0% | 0.96% | – |
| CPRX | CATALYST PHARMACEUTICALS INC | $8,610,000 | -3.7% | 8,200,000 | 0.0% | 0.96% | +19.4% | |
| ELGX | Buy | ENDOLOGIX INC | $8,580,000 | -16.2% | 1,500,000 | +87.5% | 0.95% | +3.8% |
| CORI | CORIUM INTL INC | $7,794,000 | -27.9% | 1,919,721 | 0.0% | 0.86% | -10.7% | |
| SBBP | Buy | STRONGBRIDGE BIOPHARMA PLC | $6,947,000 | -19.7% | 2,894,581 | +74.7% | 0.77% | -0.5% |
| IDRA | Buy | IDERA PHARMACEUTICALS INC | $6,642,000 | +6.9% | 4,427,745 | +82.4% | 0.74% | +32.3% |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $5,854,000 | +206.3% | 562,875 | +237.3% | 0.65% | +280.1% |
| ADMA | ADMA BIOLOGICS INC | $5,700,000 | -29.3% | 1,113,293 | 0.0% | 0.63% | -12.3% | |
| MDT | New | MEDTRONIC PLC | $5,342,000 | – | 75,000 | +100.0% | 0.59% | – |
| PCRX | PACIRA PHARMACEUTICALS INC | $4,867,000 | -5.6% | 150,680 | 0.0% | 0.54% | +16.9% | |
| GKOS | New | GLAUKOS CORP | $4,847,000 | – | 141,300 | +100.0% | 0.54% | – |
| PCRX | PACIRA PHARMACEUTICALS INCcall | $4,845,000 | -5.6% | 150,000 | 0.0% | 0.54% | +17.0% | |
| SCYX | SCYNEXIS INC | $4,713,000 | -17.6% | 1,477,273 | 0.0% | 0.52% | +2.1% | |
| ADHD | Buy | ALCOBRA LTD | $4,320,000 | -14.6% | 2,057,106 | +0.5% | 0.48% | +6.0% |
| AVIR | AVIRAGEN THERAPEUTICS INC | $4,289,000 | -35.9% | 3,486,711 | 0.0% | 0.48% | -20.7% | |
| EGLTQ | Sell | EGALET CORP | $4,255,000 | -50.7% | 556,233 | -51.0% | 0.47% | -39.0% |
| NVET | Buy | NEXVET BIOPHARMA PUB LTD CO | $4,205,000 | -0.4% | 1,127,200 | +10.8% | 0.47% | +23.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $3,924,000 | -40.6% | 826,001 | -17.4% | 0.44% | -26.4% |
| TENX | TENAX THERAPEUTICS INC | $3,839,000 | -15.8% | 1,968,631 | 0.0% | 0.43% | +4.4% | |
| New | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $3,565,000 | – | 15,500,000 | +100.0% | 0.40% | – | |
| NVRO | Sell | NEVRO CORP | $3,145,000 | -40.4% | 43,281 | -14.4% | 0.35% | -26.2% |
| MDWD | Buy | MEDIWOUND LTD | $2,899,000 | -29.1% | 633,102 | +19.2% | 0.32% | -12.0% |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $2,887,000 | -95.2% | 407,188 | -92.1% | 0.32% | -94.0% |
| RDHL | Sell | REDHILL BIOPHARMA LTDsponsored ads | $2,631,000 | -73.6% | 251,509 | -64.9% | 0.29% | -67.3% |
| CFRX | CONTRAFECT CORP | $2,501,000 | -29.4% | 1,429,109 | 0.0% | 0.28% | -12.6% | |
| PTN | New | PALATIN TECHNOLOGIES INC | $1,943,000 | – | 3,846,154 | +100.0% | 0.22% | – |
| CGNT | New | COGENTIX MED INC | $1,515,000 | – | 753,773 | +100.0% | 0.17% | – |
| TRUP | Sell | TRUPANION INC | $1,041,000 | -61.2% | 67,065 | -57.7% | 0.12% | -51.7% |
| WINT | WINDTREE THERAPEUTICS INC | $972,000 | -51.2% | 777,797 | 0.0% | 0.11% | -39.3% | |
| DXTRQ | Sell | DEXTERA SURGICAL INC | $803,000 | -49.4% | 836,367 | -0.9% | 0.09% | -37.3% |
| SSKN | STRATA SKIN SCIENCES INC | $423,000 | -17.1% | 961,422 | 0.0% | 0.05% | +2.2% | |
| RXII | Exit | RXI PHARMACEUTICALS CORP NEW | $0 | – | -316,010 | -100.0% | -0.05% | – |
| CASM | Exit | CAS MED SYS INC | $0 | – | -562,030 | -100.0% | -0.09% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -334,300 | -100.0% | -0.23% | – |
| TRVN | Exit | TREVENA INC | $0 | – | -492,000 | -100.0% | -0.30% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -1,154,674 | -100.0% | -0.33% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -15,500,000 | -100.0% | -0.39% | – | |
| HRTX | Exit | HERON THERAPEUTICS INCcall | $0 | – | -300,000 | -100.0% | -0.46% | – |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -230,532 | -100.0% | -0.49% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -664,800 | -100.0% | -0.53% | – |
| Exit | EGALET CORPnote 5.500% 4/0 | $0 | – | -10,000,000 | -100.0% | -0.79% | – | |
| DEPO | Exit | DEPOMED INC | $0 | – | -379,474 | -100.0% | -0.85% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -638,600 | -100.0% | -0.91% | – |
| QLTI | Exit | QLT INC | $0 | – | -5,269,831 | -100.0% | -0.97% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -4,361,291 | -100.0% | -1.16% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -1,347,810 | -100.0% | -1.27% | – |
| MDGN | Exit | MEDGENICS INC | $0 | – | -3,370,306 | -100.0% | -1.68% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -410,000 | -100.0% | -1.70% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -500,000 | -100.0% | -2.97% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.